Prasad Thota

620 total citations
32 papers, 336 citations indexed

About

Prasad Thota is a scholar working on Toxicology, Infectious Diseases and Economics and Econometrics. According to data from OpenAlex, Prasad Thota has authored 32 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Toxicology, 8 papers in Infectious Diseases and 6 papers in Economics and Econometrics. Recurrent topics in Prasad Thota's work include Pharmacovigilance and Adverse Drug Reactions (12 papers), Pharmaceutical Economics and Policy (6 papers) and Computational Drug Discovery Methods (4 papers). Prasad Thota is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (12 papers), Pharmaceutical Economics and Policy (6 papers) and Computational Drug Discovery Methods (4 papers). Prasad Thota collaborates with scholars based in India, Bangladesh and Australia. Prasad Thota's co-authors include Vivekanandan Kalaiselvan, Manisha Prajapat, Bikash Medhi, Hardeep Kaur, Subodh Kumar, Phulen Sarma, Saurabh Sharma, Anusuya Bhattacharyya, Seema Bansal and Dibbanti HariKrishnaReddy and has published in prestigious journals such as European Journal of Pharmacology, Safety Science and PeerJ.

In The Last Decade

Prasad Thota

27 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Prasad Thota India 12 118 114 42 36 35 32 336
Tülin Sevim Türkiye 9 398 3.4× 26 0.2× 20 0.5× 8 0.2× 8 0.2× 21 554
William Kudzi Ghana 10 51 0.4× 8 0.1× 22 0.5× 8 0.2× 5 0.1× 23 340
А. С. Колбин Russia 7 62 0.5× 8 0.1× 26 0.6× 3 0.1× 10 0.3× 143 320
Mira Desai India 12 135 1.1× 58 0.5× 42 1.0× 3 0.1× 41 403
Josipa Bukić Croatia 12 33 0.3× 20 0.2× 24 0.6× 8 0.2× 6 0.2× 43 379
Kemal Tahaoğlu Türkiye 12 517 4.4× 27 0.2× 20 0.5× 8 0.2× 3 0.1× 16 700
RK Dikshit India 10 86 0.7× 151 1.3× 43 1.0× 1 0.0× 2 0.1× 25 364
Alphienes Stanley Xavier India 12 141 1.2× 51 0.4× 71 1.7× 1 0.0× 4 0.1× 24 518
Stephanie Thee Germany 20 561 4.8× 24 0.2× 230 5.5× 9 0.3× 5 0.1× 54 990

Countries citing papers authored by Prasad Thota

Since Specialization
Citations

This map shows the geographic impact of Prasad Thota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prasad Thota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prasad Thota more than expected).

Fields of papers citing papers by Prasad Thota

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prasad Thota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prasad Thota. The network helps show where Prasad Thota may publish in the future.

Co-authorship network of co-authors of Prasad Thota

This figure shows the co-authorship network connecting the top 25 collaborators of Prasad Thota. A scholar is included among the top collaborators of Prasad Thota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prasad Thota. Prasad Thota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thota, Prasad, et al.. (2024). Engineering advances in safe laboratory design for pharmaceutical microbiology and assessment of their biohazard risk measures. Safety Science. 174. 106458–106458. 1 indexed citations
2.
3.
Khandelwal, Bidita, Madhu Gupta, Meghna Singh, et al.. (2023). Green synthesis of silver nanoparticles using Ocimum sanctum Linn. and its antibacterial activity against multidrug resistant Acinetobacter baumannii. PeerJ. 11. e15590–e15590. 19 indexed citations
4.
Thota, Prasad. (2023). "Prevalence of Microbial Contaminants in Non-sterile Pharmaceutical Antacids". Biomedical Journal of Scientific & Technical Research. 50(3).
5.
Thota, Prasad, et al.. (2021). A Comparative Study of Pharmacopoeial Quality Standards and Regulations of Radiopharmaceuticals. Indian Journal of Nuclear Medicine. 36(2). 153–162. 1 indexed citations
6.
Medhi, Bikash, Anusuya Bhattacharyya, Phulen Sarma, et al.. (2021). Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review. Indian Journal of Pharmacology. 53(4). 317–317. 43 indexed citations
7.
Kaur, Hardeep, Phulen Sarma, Anusuya Bhattacharyya, et al.. (2021). Efficacy and safety of dihydroorotate dehydrogenase (DHODH) inhibitors “leflunomide” and “teriflunomide” in Covid-19: A narrative review. European Journal of Pharmacology. 906. 174233–174233. 26 indexed citations
8.
Bhattacharyya, Anusuya, Phulen Sarma, Hardeep Kaur, et al.. (2021). COVID-19–Associated Rhino-Orbital-Cerebral Mucormycosis. Indian Journal of Pharmacology. 53(6). 499–510. 33 indexed citations
9.
Medhi, Bikash, Hardeep Kaur, Phulen Sarma, et al.. (2021). Current status of in silico, preclinical and clinical study registries across the globe: A systematic review and meta-analysis. Indian Journal of Pharmacology. 53(2). 160–160. 1 indexed citations
10.
Medhi, Bikash, Phulen Sarma, Anusuya Bhattacharyya, et al.. (2020). Efficacy and safety of steroid therapy in COVID-19: A rapid systematic review and Meta-analysis. Indian Journal of Pharmacology. 52(6). 535–535. 21 indexed citations
11.
Kaur, Harpinder, Phulen Sarma, Hardeep Kaur, et al.. (2019). Therapeutic options for management of Hori's nevus: A systematic review. Dermatologic Therapy. 33(1). 9 indexed citations
12.
Thota, Prasad, et al.. (2019). Pivotal role of Pharmacovigilance Programme of India in containment of antimicrobial resistance in India. Perspectives in Clinical Research. 10(3). 140–140. 13 indexed citations
13.
Kumar, Vipin, et al.. (2018). Cefixime-associated acute generalized exanthematous pustulosis: Rare cases in India. Indian Journal of Pharmacology. 50(4). 204–204. 6 indexed citations
14.
Thota, Prasad, et al.. (2018). Drug safety alerts of pharmacovigilance programme of India: A scope for targeted spontaneous reporting in India. Perspectives in Clinical Research. 9(1). 51–51. 11 indexed citations
15.
Hernández, Adrían V., et al.. (2017). A systematic review and meta‐analysis of the relative efficacy and safety of treatment regimens for HIV ‐associated cerebral toxoplasmosis: is trimethoprim‐sulfamethoxazole a real option?. Repositorio Académico USMP. 3 indexed citations
16.
Kalaiselvan, Vivekanandan, et al.. (2016). Pharmacovigilance Programme of India: Recent developments and future perspectives. Indian Journal of Pharmacology. 48(6). 624–624. 68 indexed citations
17.
Kalaiselvan, Vivekanandan, et al.. (2016). Risk of Intussusception with Rotavirus Vaccine. The Indian Journal of Pediatrics. 84(2). 97–100. 1 indexed citations
18.
Kalaiselvan, Vivekanandan, et al.. (2015). Quantitative Methods for the Identification of Signals for Individual Case Safety Reports in India. Therapeutic Innovation & Regulatory Science. 49(6). 898–902. 9 indexed citations
19.
Kalaiselvan, Vivekanandan, et al.. (2015). Status of documentation grading and completeness score for Indian individual case safety reports. Indian Journal of Pharmacology. 47(3). 325–325. 16 indexed citations
20.
Kalaiselvan, Vivekanandan, et al.. (2014). Spontaneous reporting of adverse drug reactions in geriatric patients in India. National Journal of Physiology Pharmacy and Pharmacology. 4(3). 225–225.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tülin Sevim Breakdown of academic impact, for papers by William Kudzi Breakdown of academic impact, for papers by А. С. Колбин Breakdown of academic impact, for papers by Mira Desai Breakdown of academic impact, for papers by Josipa Bukić Breakdown of academic impact, for papers by Kemal Tahaoğlu Breakdown of academic impact, for papers by RK Dikshit Breakdown of academic impact, for papers by Alphienes Stanley Xavier Breakdown of academic impact, for papers by Stephanie Thee
Rankless by CCL
2026